…make an attractive business case for developing treatmentsfor Nipah virus disease—a situation compounded by methodological challenges in clinical trial design. Nipah virus therapeutics development is not motivated by commercial interest….
Results for "C_SIGDA_2403學習資料 🕎 C_SIGDA_2403考試資訊 ➿ C_SIGDA_2403參考資料 🏏 在⏩ www.newdumpspdf.com ⏪網站上查找☀ C_SIGDA_2403 ️☀️的最新題庫C_SIGDA_2403考證"
IDDO and ISARIC partner to support data collection and analysis for COVID-19
…world’s largest collections of comprehensive clinical data for COVID-19. To date, the ISARIC COVID-19 database has data from more than 118,000 individuals from 648 sites across 52 countries (figures growing…
Privacy policy
…ISARIC website (www.isaric.org) (the ‘website’) in accordance with the General Data Protection Regulation (GDPR) and related UK data protection legislation. A) Who is using your personal data? ISARIC is…
Website terms of use
…loggers, spyware, adware or any other harmful programs or similar computer code designed to adversely affect the operation of any computer software or hardware. 5.2 You also agree: 5.2.1 not…
COVID-19 Rapid Evidence Reviews Group (CORRE)
…Gail.carson@ndm.ox.ac.uk Liverpool Health Protection Research Unit (HPRU) https://www.liverpool.ac.uk/infection-and-global-health/research/zoonotic-infections/hpruzoonotic/ http://www.hpruezi.nihr.ac.uk/ Tom Solomon tsolomon@liverpool.ac.uk Insight Scope http://insightscope.ca Dayre McNally dmcnally@cheo.on.ca Katie O’Hearn kohearn@cheo.on.ca REACTing https://www.glopid-r.org/clinical-trial-network/reacting-research-and-action-targeting-emerging-infectious-disease Renaud Vatrinet renaud.vatrinet@inserm.fr Collaborative Approach to Meta-Analysis…
Global consortium launches new study into long-term effects of COVID-19
The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has…
New global covid-19 long term study launched
The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites…
A global study to determine COVID-19 health and psychosocial consequences
Even as the COVID-19 pandemic enters into its ninth month, much remains unknown about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 disease. One such area is the…
ISARIC collaboration: New national study into the long-term health impacts of COVID-19 launched
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients, involving researchers from the University of Liverpool, has been launched. The PHOSP-COVID study has been…
Newly Created: GloPID-R’s Clinical Trial Networks Working Group
Various clinical trial networks are being funded by GloPID-R members to ensure a rapid clinical research response to epidemics. The Clinical Trial Networks Working Group (CTN WG) provides the opportunity…